• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Iterum Therapeutics upgraded by Gabelli & Co

    5/28/21 8:38:55 AM ET
    $ITRM
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ITRM alert in real time by email
    Gabelli & Co upgraded Iterum Therapeutics from Sell to Hold
    Get the next $ITRM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ITRM

    DatePrice TargetRatingAnalyst
    7/27/2021Sell → Hold
    Gabelli & Co.
    7/26/2021Buy → Neutral
    HC Wainwright & Co.
    More analyst ratings

    $ITRM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Whalen Joseph John

      3 - Iterum Therapeutics plc (0001659323) (Issuer)

      3/18/25 8:00:04 AM ET
      $ITRM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Hunt Ronald

      4 - Iterum Therapeutics plc (0001659323) (Issuer)

      1/23/25 6:30:04 PM ET
      $ITRM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Dunne Michael W. converted options into 106,247 units of Ordinary Shares, increasing direct ownership by 93% to 220,001 units (SEC Form 4)

      4 - Iterum Therapeutics plc (0001659323) (Issuer)

      8/12/24 9:00:05 AM ET
      $ITRM
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ITRM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Iterum Therapeutics upgraded by Gabelli & Co.

      Gabelli & Co. upgraded Iterum Therapeutics from Sell to Hold

      7/27/21 11:35:29 AM ET
      $ITRM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Iterum Therapeutics downgraded by HC Wainwright & Co.

      HC Wainwright & Co. downgraded Iterum Therapeutics from Buy to Neutral

      7/26/21 12:19:14 PM ET
      $ITRM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Iterum Therapeutics upgraded by Gabelli & Co

      Gabelli & Co upgraded Iterum Therapeutics from Sell to Hold

      5/28/21 8:38:55 AM ET
      $ITRM
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ITRM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Dunne Michael W. bought $35,000 worth of Ordinary Shares (25,000 units at $1.40), increasing direct ownership by 28% to 113,754 units (SEC Form 4)

      4 - Iterum Therapeutics plc (0001659323) (Issuer)

      12/27/23 9:00:06 AM ET
      $ITRM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dunne Michael W. bought $18,442 worth of Ordinary Shares (10,000 units at $1.84), increasing direct ownership by 13% to 88,754 units (SEC Form 4)

      4 - Iterum Therapeutics plc (0001659323) (Issuer)

      12/19/23 4:15:25 PM ET
      $ITRM
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Dunne Michael W. bought $40,690 worth of Ordinary Shares (20,000 units at $2.03), increasing direct ownership by 34% to 78,754 units (SEC Form 4)

      4 - Iterum Therapeutics plc (0001659323) (Issuer)

      11/27/23 5:00:19 PM ET
      $ITRM
      Biotechnology: Pharmaceutical Preparations
      Health Care